|
|
|
- AEC Partners was mandated by PCAS to sell its 50% stake in Créapharm
- Creapharm is a pharmaceutical contract manufacturer which produces mostly effervescent and plain tablets as well as suppositories and ovules
It also offers services for galenic and analytical development, pilot batches and stability studies
- The company was sold to Unither, a firm controlled by SG Capital Europe
Unither is a pharmaceutical contract manufacturer of sterile unit-dose vials using Blow-Fill & Seal machines
- View the press release for this transaction
- Read press articles related to this transaction
|
